Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics

Foresite Capital Management I disclosed, in a new filing with the SEC, a new passive stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI), which amasses 5.6% of the company’s common stock. The position contains around 1.6 million shares.

Karyopharm Therapeutics

Disclosure: none